Pharmapack Europe 2025: Packaging Trends
Pharmaceutical Technology® sat down with Stefan Verheyden, Global Vice President Sales Pharma & Biopharma Solutions Injectables at Gerresheimer, to talk about the primary and secondary packaging solutions Gerresheimer and Bormioli Pharma will be showcasing at Pharmapack Europe 2025 in Paris, France from January 22–23.
As a preview of what’s to come at this year’s Pharmapack Europe event, being held on January 22–23 in Paris, France, Pharmaceutical Technology® sat down with Stefan Verheyden, Global Vice President Sales Pharma & Biopharma Solutions Injectables at Gerresheimer, to talk about the different packaging solutions the company has to offer. The company will be jointly exhibiting with the newly acquired Bormioli Pharma.
At the event, Gerresheimer will be featuring its primary packaging solutions and delivery systems for sensitive biologics, such as its EZ-fill Smart packaging platform for ready-to-fill (RTF) vials and cartridges. Gerresheimer’s Gx Elite syringes, cartridges, and vials offer protection for injectable drugs, especially novel biologics, says the company (1).
Verheyden sees a trend toward at-home therapy and personalized medicine, and Gerresheimer offers autoinjectors and other drug delivery devices to accommodate this trend.
“[Our] devices actually enable a very simple, patient-friendly application with high precision dosing of the respective medication, which I think is very important. And then on top of that, [our] on-body drug delivery device can actually be digitally monitored, which I think for healthcare professionals is also very interesting, because they can pretty easily monitor the patient and how he's actually been fulfilling his treatment,” says Verheyden.
“[Gerresheimer is] becoming an organization that focuses on solutions in specific domains. Yeah, what we want to make sure … we understand what the market needs, and that we anticipate those needs. And therefore, we think it is very important that we understand very well what happens in specific … disease areas, [for example], chronic disease, … repetitive treatments, oncology, all the diseases where we think a more customized product offering could be of an added value,” Verheyden says.
Gerresheimer and Bormioli Pharma can be found at booth F55 at Pharmapack in Paris Expo, Porte de Versailles from Jan. 22–23, 2025.
Click the above video to watch the full interview.
Reference
1. Gerresheimer. Two Stories–One Future. Gerresheimer and Bormioli Pharma at Pharmapack 2025. Press Release. Jan. 20, 2025.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
